Jane Huang - Insider Trading & Ownership

Entity
Individual
Location
C/O Mourant Ozannes Corporate Services, 94 Solaris Avenue, Camana Bay, Grand Cayman, Cayman Islands
Summary
The estimated net worth of Jane Huang is at least $33.7M dollars as of October 7, 2024. Jane Huang is the CMO, Hematology of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (BGNE) stock worth about $33.2M. Jane Huang is the President, CMO of Prelude Therapeutics Inc and owns shares of Prelude Therapeutics Inc (PRLD) stock worth about $438K.
All Insider Reports
All Insider Reports

Ownership of Jane Huang

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BGNE, BEIGF BeiGene, Ltd. CMO, Hematology $33.2M Dec 14, 2021
PRLD Prelude Therapeutics Inc President, CMO $438K Oct 4, 2024
TARA Protara Therapeutics, Inc. Director Jun 7, 2024

Insider Transactions Reported by Jane Huang:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.